← All Topics / us-2026

FDA GRAS notices_csv

fda_gras_001

us-2026 6938 tok en 2026-07-18

FDA GRAS notices_csv

Total entries: 365

Source: fda_gras_notices_20260714.csv

Columns: GRN No.(sorted A-Z), Substance, Date of closure, FDA's Letter, Date of add'l correspondence, Resubmitted as GRN No.

Sample entries (first 50):

  • {"GRN No.(sorted A-Z)": "1", "Substance": "Soy isoflavone extract", "Date of closure": "Nov 3, 1998", "FDA's Letter": "At the notifier's request, FDA ceased to evaluate this notice", "Date of add'l co
  • {"GRN No.(sorted A-Z)": "2", "Substance": "Solin oil (low linolenic acid flaxseed oil or low linolenic acid linseed oil)", "Date of closure": "May 27, 1998", "FDA's Letter": "FDA has no questions", "D
  • {"GRN No.(sorted A-Z)": "3", "Substance": "Sodium bisulfate", "Date of closure": "Jun 5, 1998", "FDA's Letter": "FDA has no questions", "Date of add'l correspondence": "", "Resubmitted as GRN No.": ""
  • {"GRN No.(sorted A-Z)": "4", "Substance": "Transglutaminase fromStreptoverticillium mobaraense", "Date of closure": "Jun 22, 1998", "FDA's Letter": "FDA has no questions", "Date of add'l correspondenc
  • {"GRN No.(sorted A-Z)": "5", "Substance": "Tasteless smoke", "Date of closure": "Nov 9, 1998", "FDA's Letter": "At the notifier's request, FDA ceased to evaluate this notice", "Date of add'l correspon
  • {"GRN No.(sorted A-Z)": "6", "Substance": "Dioctyl sodium sulfosuccinate", "Date of closure": "Dec 28, 1998", "FDA's Letter": "FDA has no questions", "Date of add'l correspondence": "", "Resubmitted a
  • {"GRN No.(sorted A-Z)": "7", "Substance": "ARASCO (arachidonic acid-rich single-cell oil) and DHASCO (docosahexaenoic acid-rich single-cell oil) as sources of the fatty acids ARA (arachidonic acid) an
  • {"GRN No.(sorted A-Z)": "8", "Substance": "Pectin esterase derived fromAspergillus oryzaecarrying a gene encoding pectin esterase fromAspergillus aculeatus", "Date of closure": "Mar 2, 1999", "FDA's L
  • {"GRN No.(sorted A-Z)": "9", "Substance": "Polyglycerol polyricinoleic acid", "Date of closure": "Mar 2, 1999", "FDA's Letter": "FDA has no questions", "Date of add'l correspondence": "", "Resubmitted
  • {"GRN No.(sorted A-Z)": "10", "Substance": "Exopeptidase derived fromAspergillus oryzaecarrying a gene encoding a leucine aminopeptidase fromAspergillus sojae", "Date of closure": "Jan 29, 1999", "FDA
  • {"GRN No.(sorted A-Z)": "11", "Substance": "Calcium casein peptone-calcium phosphate", "Date of closure": "Jan 29, 1999", "FDA's Letter": "FDA has no questions", "Date of add'l correspondence": "", "R
  • {"GRN No.(sorted A-Z)": "12", "Substance": "Mesquite wood alcoholic extract", "Date of closure": "Mar 11, 1999", "FDA's Letter": "At the notifier's request, FDA ceased to evaluate this notice", "Date
  • {"GRN No.(sorted A-Z)": "13", "Substance": "Botanicals: Chrysanthemum; Licorice; Jellywort ANDHoneysuckle; Lophatherum; Mulberry leaf; Frangipani; Selfheal; Sophora flower bud", "Date of closure": "Ju
  • {"GRN No.(sorted A-Z)": "14", "Substance": "Hydrogen peroxide", "Date of closure": "May 26, 1999", "FDA's Letter": "Notice does not provide a basis for a GRAS determination", "Date of add'l correspond
  • {"GRN No.(sorted A-Z)": "15", "Substance": "Tasteless smoke(Resubmission of GRN5)", "Date of closure": "Mar 10, 2000", "FDA's Letter": "FDA has no questions", "Date of add'l correspondence": "", "Resu
  • {"GRN No.(sorted A-Z)": "16", "Substance": "Menhaden oil", "Date of closure": "Jun 8, 1999", "FDA's Letter": "At the notifier's request, FDA ceased to evaluate this notice", "Date of add'l corresponde
  • {"GRN No.(sorted A-Z)": "17", "Substance": "Arabinogalactan", "Date of closure": "Apr 11, 2000", "FDA's Letter": "At the notifier's request, FDA ceased to evaluate this notice", "Date of add'l corresp
  • {"GRN No.(sorted A-Z)": "18", "Substance": "Mesquite (Prosopisspp.) wood alcoholic extract(Resubmission of GRN12)", "Date of closure": "May 12, 1999", "FDA's Letter": "FDA has no questions", "Date of
  • {"GRN No.(sorted A-Z)": "19", "Substance": "Ferrous bisglycinate chelate", "Date of closure": "Sep 30, 1999", "FDA's Letter": "FDA has no questions", "Date of add'l correspondence": "", "Resubmitted a
  • {"GRN No.(sorted A-Z)": "20", "Substance": "Pullulanase derived fromBacillus subtiliscarrying a gene encoding pullulanase fromBacillus naganoensis", "Date of closure": "Sep 30, 1999", "FDA's Letter":
  • {"GRN No.(sorted A-Z)": "21", "Substance": "Pork collagen", "Date of closure": "Jul 29, 1999", "FDA's Letter": "FDA has no questions", "Date of add'l correspondence": "", "Resubmitted as GRN No.": ""}
  • {"GRN No.(sorted A-Z)": "22", "Substance": "alpha-Amylase derived fromBacillus licheniformiscarrying a gene encoding a modified alpha-amylase derived fromBacillus lichenformisandBacillus amyloliquefac
  • {"GRN No.(sorted A-Z)": "23", "Substance": "Protein preparation from animal blood", "Date of closure": "Aug 2, 1999", "FDA's Letter": "At the notifier's request, FDA ceased to evaluate this notice", "
  • {"GRN No.(sorted A-Z)": "24", "Substance": "alpha-Amylase derived fromBacillus licheniformiscarrying a gene encoding alpha-amylase fromBacillus stearothermophilus", "Date of closure": "May 15, 2000",
  • {"GRN No.(sorted A-Z)": "25", "Substance": "Extract ofGarcinia kolaseed (\"bitter cola\")", "Date of closure": "Oct 12, 1999", "FDA's Letter": "Notice does not provide a basis for a GRAS determination
  • {"GRN No.(sorted A-Z)": "26", "Substance": "Isolated wheat protein", "Date of closure": "Dec 16, 1999", "FDA's Letter": "FDA has no questions", "Date of add'l correspondence": "", "Resubmitted as GRN
  • {"GRN No.(sorted A-Z)": "27", "Substance": "Dextranase fromChaetomium gracile", "Date of closure": "Dec 16, 1999", "FDA's Letter": "FDA has no questions", "Date of add'l correspondence": "", "Resubmit
  • {"GRN No.(sorted A-Z)": "28", "Substance": "Seaweed-derived calcium", "Date of closure": "Apr 21, 2000", "FDA's Letter": "FDA has no questions", "Date of add'l correspondence": "Mar 19, 2014Mar 27, 20
  • {"GRN No.(sorted A-Z)": "29", "Substance": "Transglutaminase fromStreptoverticillium mobaraense", "Date of closure": "Dec 29, 1999", "FDA's Letter": "FDA has no questions", "Date of add'l corresponden
  • {"GRN No.(sorted A-Z)": "30", "Substance": "Crospovidone-cranberry juice extract", "Date of closure": "Dec 20, 1999", "FDA's Letter": "Notice does not provide a basis for a GRAS determination", "Date
  • {"GRN No.(sorted A-Z)": "31", "Substance": "Cetylpyridinium chloride", "Date of closure": "Jan 10, 2000", "FDA's Letter": "At the notifier's request, FDA ceased to evaluate this notice", "Date of add'
  • {"GRN No.(sorted A-Z)": "32", "Substance": "Pectin lyase derived fromTrichoderma reeseicarrying a gene encoding pectin lyase fromAspergillus niger", "Date of closure": "Apr 20, 2000", "FDA's Letter":
  • {"GRN No.(sorted A-Z)": "33", "Substance": "Low erucic acid oil derived fromBrassica juncea", "Date of closure": "Jan 27, 2000", "FDA's Letter": "FDA has no questions", "Date of add'l correspondence":
  • {"GRN No.(sorted A-Z)": "34", "Substance": "Aspartic proteinase derived fromAspergillus oryzaecarrying a gene encoding aspartic proteinase fromRhizomucor miehei", "Date of closure": "Apr 19, 2000", "F
  • {"GRN No.(sorted A-Z)": "35", "Substance": "Hempseed oil", "Date of closure": "Aug 24, 2000", "FDA's Letter": "Notice does not provide a basis for a GRAS determination", "Date of add'l correspondence"
  • {"GRN No.(sorted A-Z)": "36", "Substance": "Chromium picolinate;Ginkgo bilobaleaf extract; and Ginseng extract", "Date of closure": "Apr 10, 2000", "FDA's Letter": "At the notifier's request, FDA ceas
  • {"GRN No.(sorted A-Z)": "37", "Substance": "Whey protein isolate and dairy product solids", "Date of closure": "Apr 21, 2000", "FDA's Letter": "FDA has no questions", "Date of add'l correspondence": "
  • {"GRN No.(sorted A-Z)": "38", "Substance": "Cetylpyridinium chloride(Resubmission of GRN31)", "Date of closure": "Feb 29, 2000", "FDA's Letter": "Notice does not provide a basis for a GRAS determinati
  • {"GRN No.(sorted A-Z)": "39", "Substance": "Tall oil phytosterols", "Date of closure": "Apr 24, 2000", "FDA's Letter": "FDA has no questions", "Date of add'l correspondence": "Nov 2, 2000", "Resubmitt
  • {"GRN No.(sorted A-Z)": "40", "Substance": "Mineral oil", "Date of closure": "Dec 11, 2000", "FDA's Letter": "Notice does not provide a basis for a GRAS determination", "Date of add'l correspondence":
  • {"GRN No.(sorted A-Z)": "41", "Substance": "DHASCO (docosahexaenoic acid-rich single-cell oil) and ARASCO (arachidonic acid-rich single-cell oil)(Resubmission of GRN7)", "Date of closure": "May 17, 20
  • {"GRN No.(sorted A-Z)": "42", "Substance": "Milk-derived lactoferrin", "Date of closure": "Mar 26, 2001", "FDA's Letter": "Notice does not provide a basis for a GRAS determination", "Date of add'l cor
  • {"GRN No.(sorted A-Z)": "43", "Substance": "Lipase derived fromAspergillus oryzaecarrying a gene encoding lipase fromThermomyces lanuginosus", "Date of closure": "Sep 22, 2000", "FDA's Letter": "FDA h
  • {"GRN No.(sorted A-Z)": "44", "Substance": "Fructooligosaccharide", "Date of closure": "Nov 22, 2000", "FDA's Letter": "FDA has no questions", "Date of add'l correspondence": "Jun 1, 2007", "Resubmitt
  • {"GRN No.(sorted A-Z)": "45", "Substance": "Trehalose", "Date of closure": "Oct 5, 2000", "FDA's Letter": "FDA has no questions", "Date of add'l correspondence": "", "Resubmitted as GRN No.": ""}
  • {"GRN No.(sorted A-Z)": "46", "Substance": "Gamma cyclodextrin", "Date of closure": "Sep 22, 2000", "FDA's Letter": "FDA has no questions", "Date of add'l correspondence": "", "Resubmitted as GRN No."
  • {"GRN No.(sorted A-Z)": "47", "Substance": "Arabinogalactan fromLarix occidentalis(Resubmission of GRN17)", "Date of closure": "Jun 6, 2000", "FDA's Letter": "FDA has no questions", "Date of add'l cor
  • {"GRN No.(sorted A-Z)": "48", "Substance": "Vegetable oil phytosterol esters", "Date of closure": "Nov 27, 2000", "FDA's Letter": "FDA has no questions", "Date of add'l correspondence": "", "Resubmitt
  • {"GRN No.(sorted A-Z)": "49", "Substance": "Bifidobacterium lactisstrain Bb12 andStreptococcus thermophilusstrain Th4", "Date of closure": "Mar 19, 2002", "FDA's Letter": "FDA has no questions", "Date
  • {"GRN No.(sorted A-Z)": "50", "Substance": "Bohenin", "Date of closure": "Aug 31, 2000", "FDA's Letter": "FDA has no questions", "Date of add'l correspondence": "", "Resubmitted as GRN No.": ""}

... and 315 more

Sources

  • fda_gras_notices_20260714.csv

Machine access

AI agents: this page mirrors GET /api/v1/llm_context?topic=fda_gras_001 (max 500 tokens, whitelisted). Rate limit 60 req/min for recognized AI crawlers.

Raw JSON ↗ llm.txt OpenAPI